Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7281417 | Brain, Behavior, and Immunity | 2015 | 8 Pages |
Abstract
We demonstrate a long-term dysregulation of the kynurenine pathway in the central nervous system of suicide attempters. An increased load of inflammatory cytokines was coupled to more severe symptoms. We therefore suggest that patients with a dysregulated kynurenine pathway are vulnerable to develop depressive symptoms upon inflammatory conditions, as a result the excess production of the NMDA-receptor agonist quinolinic acid. This study provides a neurobiological framework supporting the use of NMDA-receptor antagonists in the treatment of suicidality and depression.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Cecilie Bay-Richter, Klas R. Linderholm, Chai K. Lim, Martin Samuelsson, Lil Träskman-Bendz, Gilles J. Guillemin, Sophie Erhardt, Lena Brundin,